In this issue:
Wearable devices may help detect AF
Polypill strategy for secondary prevention
Rivaroxaban vs VKA in patients with rheumatic heart disease and AF
Mortality in patients with recent acute MI receiving antithrombotic therapy
Aspirin for primary prevention in relation to lipoprotein(a) genotypes
Early rhythm control for AF
Morning vs evening dosing of antihypertensives
Up-titration of guideline-directed medical therapies for acute HF
Comparative efficacy and safety of DOACs in patients with AF
BP lowering and prevention of dementia
Please login below to download this issue (PDF)